Key result
Post-systolic shortening at 3 months predicts ~60% lower risk of MACE and revascularization after AMI.
Why the study?
To determine whether serial post-systolic shortening by speckle tracking echocardiography could predict MACE, symptom-driven infarct-related artery revascularization, and segmental function improvement after acute myocardial infarction.
Does serial post-systolic shortening by speckle tracking echocardiography predict MACE and segmental function improvement in patients with acute myocardial infarction?
Cohort (n=94)
No
Does serial post-systolic shortening by speckle tracking echocardiography predict MACE and segmental function improvement in patients with acute myocardial infarction?
Effect estimate: HR 0.4 (95% CI 0.24-0.67)
p-value: p=<0.01
Post-systolic shortening at 3 months measured by speckle tracking echocardiography is an independent predictor of MACE and symptom-driven revascularization in post-myocardial infarction patients.
May refine post-MI risk stratification; leaves open whether serial PSS assessment improves outcomes in prospective trials.
PURPOSE: The aim is to determine whether serial post-systolic shortening (PSS) using speckle tracking echocardiography (STE) could predict major adverse cardiovascular events (MACE), especially symptom-driven infarct-related artery (IRA) revascularization and improvement in segmental function in post-myocardial infarction patients. METHODS/RESULTS: Ninety-four patients (average age 61.1 ± 12.5 y, 84 [84.9%] male) with new-onset acute myocardial infarction were enrolled. Serial echocardiography was performed during the initial presentation, and at 3, 6 and 12 months after admission. PSS, strain and systolic strain rate were calculated using STE. Improvement in segmental function was defined as a decrease of ≧1 grade in wall motion score. During the follow-up (29.4 ± 12.7months), 22 patients (23.4%) had MACE and 17 patients had symptom-driven IRA revascularization. In multivariate model, PSS at 3 months was independently predictive for symptom-driven IRA revascularization (Hazard ratio (HR) = 0.5, 95% CI = 0.26-0.97) and for MACE (HR = 0.4, 95% CI = 0.24-0.67) (p < 0.05). Segmental function improvements were found in 255 segments (66.1%) and ROC curve analyses showed that AUC (95% CI) of the initial PSS was 0.7(0.65-0.77) (cut-off values = -1.08, sensitivity = 58%, specificity = 73% specificity). CONCLUSIONS: Post-systolic shortening at 3 months is an independent predictor for symptom-driven IRA revascularization and MACE. Regional wall motion recovery also could be predicted by initial PSS. Serial assessment of two-dimensional STE should be investigated in post-myocardial infarction patients in the future.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2020) conducted a cohort in Acute myocardial infarction (n=94). Post-systolic shortening (PSS) assessment by speckle tracking echocardiography was evaluated on Major adverse cardiovascular events (MACE) (HR 0.4, 95% CI 0.24-0.67, p=<0.01). Post-systolic shortening at 3 months independently predicted major adverse cardiovascular events (HR 0.4) and symptom-driven infarct-related artery revascularization after acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: